Evidence map›Paper›PMID 27847602›Full record

ReviewInternational journal of retina and vitreous2015

Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review.

Rohan Merani, Alex P Hunyor

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of retina and vitreous, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06771908 (THE ROLE OF HEXAMIDINE DIISETHIONATE), which is not on this map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06771908 recruitingnot on this mapstarted 2025, after this paper: background citation

The role of hexamidine diisethionate (zamidine®) 1mg/ml 0.6ml eye drops in the prophylaxis of surgery oftalmic

TypeobservationalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2025 to 2026Enrolled56ConditionsEye Disease, ConjunctivitisArmsConjunctival Swab
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 102 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Real-world safety and efficacy of Anti-VEGF treatment in Brazil.Arquivos brasileiros de oftalmologia · 2025
    Article
  14. Review
  15. Article
  16. Medical hypothesis, discovery & innovation ophthalmology journal · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rohan MeraniRetina Associates, Level 4, 8 Thomas St, Chatswood, NSW 2067 Australia ; grid.1013.3000000041936834XSave Sight Institute, University of Sydney, Sydney, NSW Australia ; grid.1004.50000000121585405Australian School of Advanced Medicine, Macquarie University, Sydney, NSW Australia ; grid.414685.a0000000403923935Concord Repatriation General Hospital, Concord, NSW Australia.
Alex P HunyorRetina Associates, Level 4, 8 Thomas St, Chatswood, NSW 2067 Australia ; grid.1013.3000000041936834XSave Sight Institute, University of Sydney, Sydney, NSW Australia ; grid.1004.50000000121585405Australian School of Advanced Medicine, Macquarie University, Sydney, NSW Australia ; grid.416790.d0000000406258248Sydney Eye Hospital, Sydney, NSW Australia.
Retina Associates · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this review is to report and summarize previously reported studies and assess many of the individual steps of the intravitreal injection procedure's possible effect on the prevention of endophthalmitis. The pooled endophthalmitis rate from 20 large retrospective case series of anti-VEGF injections was 144/510,396 (0.028%; 1/3,544). Injections may be performed in an office-based location or in an operating room (OR) and low rates of endophthalmitis can be achieved in either location with careful attention to asepsis. Pre- or post-injection topical antibiotics have not been shown to be effective, and could select for more virulent microorganisms. Povidone-iodine prior to injection is accepted as the gold-standard antiseptic agent, but

Indexed as

AntibioticsAntisepsisAnti-VEGFChlorhexidineEndophthalmitisIntravitreal injectionMasksPovidone-IodineSpeculumStreptococcus

Identifiers

PMID27847602
PMCPMC5088471
OpenAlexW1814739832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.